Myron Holubiak
2021
In 2021, Myron Holubiak earned a total compensation of $1.7M as Chief Executive Officer at Citius Pharmaceuticals, a 91% increase compared to previous year.
Compensation breakdown
Bonus | $750,000 |
---|---|
Non-Equity Incentive Plan | $275,625 |
Option Awards | $194,978 |
Salary | $450,000 |
Total | $1,670,603 |
Holubiak received $750K in bonus, accounting for 45% of the total pay in 2021.
Holubiak also received $275.6K in non-equity incentive plan, $195K in option awards and $450K in salary.
Rankings
In 2021, Myron Holubiak's compensation ranked 6,779th out of 12,415 executives tracked by ExecPay. In other words, Holubiak earned more than 45.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,779 | 45th |
Manufacturing | 2,946 | 47th |
Chemicals And Allied Products | 1,302 | 45th |
Drugs | 1,160 | 45th |
Pharmaceutical Preparations | 846 | 45th |
Holubiak's colleagues
We found three more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2021.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018